Kercheville Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,185
Closed -$210K 94
2022
Q2
$210K Sell
1,185
-1,800
-60% -$321K 0.14% 75
2022
Q1
$529K Sell
2,985
-25
-0.8% -$4.25K 0.25% 62
2021
Q4
$515K Buy
3,010
+175
+6% +$28.6K 0.22% 68
2021
Q3
$458K Sell
2,835
-132
-4% -$22.5K 0.22% 71
2021
Q2
$489K Sell
2,967
-398
-12% -$65.9K 0.23% 72
2021
Q1
$552K Sell
3,365
-85
-2% -$13.8K 0.28% 71
2020
Q4
$543K Buy
+3,450
New +$509K 0.3% 65

Other funds holding JNJ

Kercheville Advisors's JNJ Position: Q3 2022 in Review

Kercheville Advisors sold out of Johnson & Johnson (JNJ) in Q3 2022, closing a stake of 1,185 shares — an estimated $210K sold.

Kercheville Advisors first reported a position in JNJ in Q4 2020 and held it in 7 quarters. The position peaked at $552K in Q1 2021. 3,623 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.

  • Kercheville Advisors reported no remaining Johnson & Johnson position as of Q3 2022 after selling out during the quarter.
  • Kercheville Advisors sold 1,185 Johnson & Johnson shares in Q3 2022, an estimated $210K.
  • Kercheville Advisors first reported a position in Johnson & Johnson in Q4 2020 and held it in 7 quarters.
  • Kercheville Advisors's Johnson & Johnson position peaked at $552K in Q1 2021.
  • 3,623 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.

Based on Kercheville Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.